Multimodal imaging in a severe case of hydroxychloroquine toxicity.
暂无分享,去创建一个
K Bailey Freund | K. Freund | Lekha K. Mukkamala | K. Bhavsar | Kavita V Bhavsar | Lekha K Mukkamala
[1] U. Kellner,et al. Cystoid macular oedema and epiretinal membrane formation during progression of chloroquine retinopathy after drug cessation , 2013, British Journal of Ophthalmology.
[2] S. Tsang,et al. Retinal Damage in Chloroquine Maculopathy, Revealed by High Resolution Imaging: A Case Report Utilizing Adaptive Optics Scanning Laser Ophthalmoscopy , 2014, Korean journal of ophthalmology : KJO.
[3] M. Marmor,et al. Effect of disease stage on progression of hydroxychloroquine retinopathy. , 2014, JAMA ophthalmology.
[4] M. Marmor,et al. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. , 2002, Ophthalmology.
[5] Petros P Sfikakis,et al. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal. , 2003, Ophthalmology.
[6] T. Olsen,et al. Hydroxychloroquine retinopathy screening , 2008, British Journal of Ophthalmology.
[7] R. Carr,et al. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology. , 2002, Ophthalmology.
[8] M. Marmor,et al. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy. , 2014, Ophthalmology.
[9] J. S. Lyons. Impact of the revised American Academy of Ophthalmology guidelines regarding hydroxychloroquine screening on actual practice. , 2013, American journal of ophthalmology.
[10] H. Walia,et al. Hydrochloroquine retinopathy: characteristic presentation with review of screening , 2013, Clinical Rheumatology.